← All trials
NCT04981457
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 2, 2021
- Primary completion
- Sep 30, 2021
- Completion date
- Oct 31, 2021
- First posted
- Jul 29, 2021
- Last posted
- Jul 29, 2021
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cairo UniversityLead sponsor
- Cairo UniversityReponsible party - principal investigator
- Cairo UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.